Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy

Ariel Bardach, Andrea Alcaraz, Javier Roberti, Agustín Ciapponi, Federico Augustovski and Andrés Pichon-Riviere
Additional contact information
Ariel Bardach: Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina
Andrea Alcaraz: Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina
Javier Roberti: Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina
Agustín Ciapponi: Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina
Federico Augustovski: Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina
Andrés Pichon-Riviere: Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy, Ravignani 2024, Buenos Aires 1414, Argentina

IJERPH, 2021, vol. 18, issue 10, 1-13

Abstract: Introduction: In Latin America, tobacco smoking prevalence is between 6.4% and 35.2%. Governments have been making efforts to support the regulation of advertising and, in many cases, banning advertising and promotion of tobacco altogether. The objective of this study was to evaluate the potential impact on health and economic outcomes of optimizing a ban on tobacco advertising and sponsorship in Argentina, Bolivia, Brazil, Chile, Colombia, Mexico, and Peru. Methods: We built a probabilistic microsimulation model, considering natural history, direct health system costs, and quality of life impairment associated with main tobacco-related diseases. We followed individuals in hypothetical cohorts and calculated health outcomes on an annual basis to obtain aggregated 10-year population health outcomes (deaths, events, healthy years of life) and costs. To populate the model, we performed a rapid review of literature to calculate intervention effectiveness. Results: With current policies, over 10 years, in Argentina, Bolivia, Brazil, Chile, and Colombia a total of 50,000 deaths and 364,000 disease events will be averted, saving $7.2 billion. If the seven countries strengthened their policies and implemented a comprehensive ban with 100% compliance, 98,000 deaths and 648,000 events would be averted over 10 years, saving almost $15 billion in healthcare costs. Conclusions: Optimizing a ban on tobacco advertising and sponsorship would substantially reduce deaths, diseases, and health care costs attributed to smoking. Latin American countries should not delay the full implementation of this strategy.

Keywords: tobacco; smoking; advertising and sponsorship ban; financial benefits; health benefits; Latin America (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/10/5078/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/10/5078/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:10:p:5078-:d:552336

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().